ClinConnect ClinConnect Logo
Search / Trial NCT06191419

Human Perception of Odors and Odor Blockers

Launched by TIM MCCLINTOCK · Dec 20, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Odors Sensory Perception Nicotine Addiction Motivation

ClinConnect Summary

This clinical trial is studying whether certain odor blockers can help people quit smoking by making the smell of cigarette smoke less intense and less appealing. The main question is whether these blockers can reduce the urge to smoke by changing how strongly people perceive the odors associated with smoking. If you’re a smoker and are interested in finding a new way to help you quit, this might be a good opportunity for you.

Participants will take part in sessions where they will smell up to 20 different odors and then share how pleasant they find those smells and whether they feel a desire to smoke afterward. To join the study, you need to be a smoker. Unfortunately, if you don't smoke or if you have trouble smelling or tasting, you won't be eligible to participate. This trial is currently recruiting participants aged between 18 to 75, and both men and women can join.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Smoker
  • Exclusion Criteria:
  • Non Smoker
  • Self reported inability to smell or taste

About Tim Mcclintock

Tim McClintock is a dedicated clinical trial sponsor with extensive experience in the design and management of innovative research studies. Committed to advancing medical knowledge and improving patient outcomes, McClintock leverages a collaborative approach, working closely with healthcare professionals, regulatory bodies, and research organizations. His focus spans various therapeutic areas, emphasizing rigorous adherence to ethical standards and regulatory compliance. By fostering a culture of transparency and accountability, Tim McClintock aims to deliver high-quality clinical trials that contribute to the development of effective treatments and therapies.

Locations

Lexington, Kentucky, United States

Patients applied

0 patients applied

Trial Officials

Timothy McClintock, PhD

Principal Investigator

University of Kentucky

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported